The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...

Delfi Diagnostics is combining AI and liquid biopsy tech to make routine blood tests a powerful tool against cancer —starting ...

The St. Louis Business Journal's annual Best Places to Work Awards recognize the top workplaces in the St. Louis region and ...

The donation will help expand the ECMO Program, which stands for Extracorporeal Membrane Oxygenation.

"While maybe a few years ago we could have been categorized as an online learning company, we're now more of an AI-enabled ...

A coalition of chamber leaders is proposing an innovative campus in Northeast Portland that could redefine how the city ...

The stunning breakdown between the county and its top riverfront legal adviser comes at a critical time, but Prosecutor ...

The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

Our guest contributor argues that pending budget cuts at the Corporation for Public Broadcasting are an important issue for ...

Central Catholic High School plans a major expansion, including a new 102,000-square-foot student center with gym, classrooms ...

The large Birmingham organization has named a leader from the Midwest. Executive profile: Longtime YMCA leader reflects as ...